Загрузка...
Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications
Glioblastoma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. Bevacizumab, a monoclonal antibody against the vascular endothelial growth factor receptor, has increasingly been used in the treatment of recurrent glioblastoma. It has...
Сохранить в:
| Опубликовано в: : | Brain Tumor Res Treat |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433944/ https://ncbi.nlm.nih.gov/pubmed/28516072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14791/btrt.2017.5.1.1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|